This white paper will take you through five facets of IP that are particularly important for businesses relying on IP that has originated from their time at a university or other higher education facility.
It has now been confirmed that the Unitary Patent (UP) and the Unified Patent Court (UPC) are intended to come into force on the 1 April 2023.
In this white paper we will look at how licensing models benefit both the licensor and the licensee and provide advice on best practice to create the licensing model you need to deliver your commercial objectives.
Discover CleanTech spoke to Potter Clarkson patent attorney Sara Holland about her passion for synthetic biology, the work of a patent attorney, and why scientists need solid IP strategies to change the world for the better.
Anna has just joined Potter Clarkson this summer and Potter Clarkson’s Tom Harding sat down to chat with her at the Nordic Life Science Days conference.
In this article by Sarah Speight, Sheena Linehan has been quoted alongside the director of IP at the World Trade Organisation and the global patent head of an international law firm.
Dave Holt, senior associate and licensing specialist, comments on the recent Court of Appeal decision Neurim v Generics [2022] EWCA Civ 359 and its implications on licensing Unitary Patents.
According to many, the anticipated arrival of Humira biosimilars in the US next year has pushed AbbVie's drug to the precipice of the pharma industry’s biggest-ever patent cliff.
Patent Offices around the world are busy preparing for the ‘big bang’ date of 1 July 2022 on which the new international standard for providing sequence listings (Standard ST.26) will come into force, simultaneously replacing existing Standard ST.25. Applicants and their representatives will need to be aware of the change and its consequences to avoid difficulties.
Aarhus Investor Summit | Science Edition is taking place at INCUBA Navitas in central Aarhus on 18 May 2022. This event connects investors with early stage spinouts and researchers looking to commercialize research-based inventions and solutions.
LSX World Congress is taking place in London, UK on 10-11 May 2022. This event gathers the founders and CEOs of innovative biotech, medtech and healthtech start-ups through to healthcare giants, and everyone in between.
A recent case involving Bristol Myers Squibb, which resulted in the revocation of a patent filed by the pharmaceutical giant, serves as a salutary warning on the risks of failing to include detailed supporting data when an application is first filed.
Two of our IP specialists in probiotics and microbiology will be attending this year’s Probiota event in Copenhagen, Denmark, to learn from and network with delegates in academia and industry.
The Court of Justice of the EU (CJEU) has once again been asked to explain the eligibility criteria for SPCs for “combination products” - those comprising two or more active ingredients.
The European Commission has opened a call for evidence on proposals for a single procedure for the granting of SPCs across the European Union.